ENTITY
Johnson & Johnson

Johnson & Johnson (JNJ US)

243
Analysis
Health CareUnited States
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
more
Refresh
bullishAbbvie Inc
11 Jun 2024 03:00Issuer-paid

Abbvie Inc - Regenerative Healthcare - Stem Cells & ALS Thematic 10062024

Regenerative medicine remains an extremely exciting area of healthcare with vast investment potential. In spite of the usual setbacks in valuation...

Logo
194 Views
Share
05 Jan 2024 09:35Issuer-paid

Shroom Shmooz - Spotlight on Ketamine

‘Friends’ actor Matthew Perry’s untimely death last October has introduced ketamine to a broader market in an unfortunate way.

Logo
419 Views
Share
22 May 2023 11:03Issuer-paid

Johnson & Johnson Inc. - Equity Research Flash Note - March 24, 2023

The Company is engaged in the re- search and development, manufacture and sale of a range of products in the healthcare field.

bullishPfizer
12 Apr 2021 00:00Exchange-sponsored

SGX Asia Currencies and Commodities Insights

By Macro Hive   SGX Asia Currencies Insights CNH has traded well against most currencies, and flows remain strong. Therefore, recent USD/CNH...

Share
19 May 2020 00:00Exchange-sponsored

Biolidics, iX Biopharma & Hyphens Pharma Outpace Peers in 2020 YTD

Singapore’s most traded primary-listed stocks that represent medical equipment manufacturing, biotech and pharmaceuticals all generated gains...

Share
x